Kang Ming (康明)康明
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 镇江恒新药业有限公司Chinese legal name: 镇江恒新药业有限公司
主要成分Active Ingredients
- 其组份为:每瓶含消旋山莨菪碱Recorded Chinese composition: 其组份为:每瓶含消旋山莨菪碱
- 软骨素Ruangu Su
药物知识说明
其组份为:每瓶含消旋山莨菪碱是一种在国家药监局注册认定的药品。该药品含有软骨素-a92d9cc0等成分。
该药品关联的活性成分包括：软骨素Ruangu Su。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：镇江恒新药业有限公司Chinese legal name: 镇江恒新药业有限公司。
您可以探索含有相同成分的其他药品：软骨素-a92d9cc0成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 康明) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 软骨素Ruangu Su.
Manufacturers recorded for this product: 镇江恒新药业有限公司Chinese legal name: 镇江恒新药业有限公司.
Explore other medicines containing the same ingredient: 软骨素 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 康明Recorded Chinese name: 康明
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 5ml:消旋山莨菪碱1.0mg:硫酸软骨素0.1gRecorded Chinese specification: 5ml:消旋山莨菪碱1.0mg:硫酸软骨素0.1g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 镇江恒新药业有限公司Chinese legal name: 镇江恒新药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10910087
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10910087
Manufacturer
Chinese legal name: 镇江恒新药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10910087
生产企业
镇江恒新药业有限公司(国产)
适应症
用于青少年假性近视。
用法用量
滴眼。滴后闭眼1分钟，一日2次，一次1-2滴，一个月为1疗程。
不良反应
1.口干，面红。|2.少见的有心率加快，排尿困难等反应。|3.少数患者可发生唾液腺肿胀，偶有过敏反应，甚至过敏性休克。|4.滴眼后有轻微散瞳作用。
禁忌
1.脑出血急性期禁用。|2.前列腺肥大及青光眼患者禁用。
注意事项
请将本品放在儿童接触不到的地方。
贮藏
密封保存。
规格
5ml:消旋山莨菪碱1.0mg:硫酸软骨素0.1g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.